ALGS 8-K: SEC filing
Aligos Therapeutics
Filed with the SEC on · accession 0001171843-26-007214
ALGS filed a 8-K (current report) with the SEC on Nov 6, 2026. Aligos Therapeutics reported Q3 2026 financial results with a net loss of $21.9 million and cash of $31.1 million, expected to fund operations only into Q1 2027.
Summary of the filing
Aligos Therapeutics reported Q3 2026 financial results with a net loss of $21.9 million and cash of $31.1 million, expected to fund operations only into Q1 2027. The company also provided pipeline updates, including completed enrollment in the Phase 2 B-SUPREME study of pevifoscorvir sodium with topline data expected in late Q3 2027.
Key details
✦ Ask GOAX AI about this filing — what it means for ALGS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ALGS?
Click hereFrequently asked questions
What did ALGS file with the SEC on Nov 6, 2026?
ALGS filed a 8-K (SEC filing). Aligos Therapeutics reported Q3 2026 financial results with a net loss of $21.9 million and cash of $31.1 million, expected to fund operations only into Q1 2027. The company also provided pipeline updates, including completed enrollment in the Phase 2 B-SUPREME study of pevifoscorvir sodium with topline data expected in late Q3 2027.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other ALGS SEC filings
Get alerts when ALGS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days